Hirulog and Early Reperfusion or Occlusion Trial - HERO-2

Description:

A randomized, open-label trial comparing bivalirudin (a thrombin-specific anticoagulant) with heparin in patients undergoing fibrinolysis with streptokinase for acute MI.